In the present study, we examined the uterine relaxant activity of 4-chloro-7-trifluoromethyl-10H-benzo[4,5]furo[3,2-b]indole-1-carboxylic acid (TBIC), a putative opener of the large conductance Ca2+-activated K+ (BKCa) channel. TBIC concentration-dependently inhibited spontaneous uterine contractions (EC50 = 4.63 µmol/l; Emax = 94.85 ± 1.85%; 100 µmol/l, n = 6). It also reduced contractions induced by oxytocin (EC50 = 4.10 µmol/l; Emax = 84.3 ± 3.83%; 100 µmol/l, n = 6), prostaglandin F2α (EC50 = 2.14 µmol/l; Emax = 73.70 ± 5.21%; 100 µmol/l, n = 6) and acetylcholine (EC50 = 4.37 µmol/l; Emax = 83.67 ± 4.82; 100 µmol/l, n = 6). TBIC decreased KCl (20 mmol/l) -induced contractions (EC50 = 3.04 µmol/l; Emax = 94.0 ± 3.12%; 100 µmol/l, n = 6) indicating its K+ channel opening activity. BKCa channel blockers penitrem A (100 nmol/l) and tetraethylammonium chloride (1 mmol/l) attenuated the inhibitory activities of TBIC (p < 0.001) but not other K+ channel blockers such as barium chloride and glibenclamide (KIR and KATP channel blockers, respectively). These results demonstrate the uterine relaxant effects of TBIC in a mechanism of action largely referable to the potentiation of the BKCa channels. We have provided evidence for the potential use of TBIC as a tocolytic agent and support for the utility of BKCa channel openers in pathophysiologic conditions involving smooth muscle hyperactivity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.